"Can Oligonucleotides Target RNA Splicing to Treat Disease?" from OTS

  • Thread starter Thread starter JonMoulton
  • Start date Start date
  • Tags Tags
    Disease Rna
AI Thread Summary
Oligonucleotides show promise in targeting RNA splicing as a therapeutic approach for various diseases, including cancer and genetic disorders. Evidence indicates their effectiveness in addressing specific genetic mutations, particularly in cancer treatment, and ongoing research aims to expand their application to other genetic mutations. Furthermore, oligonucleotides are being investigated for their potential to modulate gene expression related to metabolic and neurological disorders. Overall, oligonucleotides represent a significant advancement in the treatment of diseases through RNA splicing targeting.
Biology news on Phys.org
Yes, it appears that oligonucleotides can target RNA splicing to treat disease. In fact, there is a growing body of evidence that suggests that this type of therapy may be useful in treating a wide range of diseases, including cancer and genetic disorders. Oligonucleotides have already been used to target specific genetic mutations in some cancers, and they are being further developed to target other types of genetic mutations as well. Additionally, researchers are exploring ways to use oligonucleotides to modulate the expression of genes involved in various diseases, including metabolic and neurological disorders. Therefore, it appears that oligonucleotides have great potential for targeting RNA splicing in order to treat a variety of diseases.
 
Popular article referring to the BA.2 variant: Popular article: (many words, little data) https://www.cnn.com/2022/02/17/health/ba-2-covid-severity/index.html Preprint article referring to the BA.2 variant: Preprint article: (At 52 pages, too many words!) https://www.biorxiv.org/content/10.1101/2022.02.14.480335v1.full.pdf [edited 1hr. after posting: Added preprint Abstract] Cheers, Tom
Back
Top